These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2669756)

  • 21. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
    Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
    Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
    Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo potency of insulin analogues designed for clinical use.
    Vølund A; Brange J; Drejer K; Jensen I; Markussen J; Ribel U; Sørensen AR; Schlichtkrull J
    Diabet Med; 1991 Nov; 8(9):839-47. PubMed ID: 1663018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of insulin fragments on biological activity of insulin and desoctapeptide insulin. II. Enhanced binding and mechanism studies.
    Kikuchi K; Larner J; Freer RJ; Day AR
    J Biol Chem; 1981 Sep; 256(18):9445-9. PubMed ID: 7026554
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of insulin fragments on biological activity of insulin and desoctapeptide insulin. I. Potentiation of biological activities.
    Kikuchi K; Larner J; Freer RJ; Day AR
    J Biol Chem; 1981 Sep; 256(18):9441-4. PubMed ID: 7026553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor.
    Kurose T; Pashmforoush M; Yoshimasa Y; Carroll R; Schwartz GP; Burke GT; Katsoyannis PG; Steiner DF
    J Biol Chem; 1994 Nov; 269(46):29190-7. PubMed ID: 7961885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actions of insulin-potentiating peptides on glycogen synthesis.
    Ng FM; Larner J
    Diabetes; 1976 May; 25(5):413-9. PubMed ID: 817952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The minimal amino acid sequence of the insulin-potentiating fragments of human growth hormone: its mechanism of action.
    Ng FM; Bornstein J; Pullin CE; Bromley JO; Macaulay SL
    Diabetes; 1980 Oct; 29(10):782-7. PubMed ID: 6777219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of modified insulin B21-B26 fragments on glycogenesis and on insulin-receptor complex fate in cultured fetal hepatocytes.
    Menuelle P; Plas C; Taketomi S
    Mol Cell Endocrinol; 1989 Oct; 66(2):143-51. PubMed ID: 2693157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced specific insulin binding and insulin action with C-terminal B-chain pentapeptide derived from insulin.
    Kikuchi K; Larner J; Freer R; Day AR
    FEBS Lett; 1980 Sep; 119(1):161-4. PubMed ID: 6775976
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
    Nakagawa SH; Tager HS
    J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-function relationships of des-(B26-B30)-insulin.
    Spoden M; Gattner HG; Zahn H; Brandenburg D
    Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine.
    Du H; Shi J; Cui D; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):133-9. PubMed ID: 18235975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
    Burke GT; Chanley JD; Okada Y; Cosmatos A; Ferderigos N; Katsoyannis PG
    Biochemistry; 1980 Sep; 19(20):4547-56. PubMed ID: 7000179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).
    Schwartz GP; Burke GT; Katsoyannis PG
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):458-61. PubMed ID: 2643113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of neonatal insulin treatment on adult receptor binding capacity in rats.
    Inczefi-Gonda A; Csaba G; Dobozy O
    Horm Metab Res; 1982 Apr; 14(4):221-2. PubMed ID: 7044935
    [No Abstract]   [Full Text] [Related]  

  • 37. Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.
    Peavy DE; Brunner MR; Duckworth WC; Hooker CS; Frank BH
    J Biol Chem; 1985 Nov; 260(26):13989-94. PubMed ID: 4055768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute metabolic actions of des-(B27-B30)-insulin and related analogues in adult rats.
    Hartmann H; Korf J; Ottmers U; Creutzfeldt W
    Acta Diabetol; 1993; 30(2):108-14. PubMed ID: 8219258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
    Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
    Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of semisynthetic insulin analogues from bis(tert-butyloxycarbonyl)-desoctapeptide-insulin phenylhydrazide: importance of the aromatic region B24-B26.
    Riemen MW; Pon LA; Carpenter FH
    Biochemistry; 1983 Mar; 22(6):1507-15. PubMed ID: 6340739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.